TAIM
DGX icon

Te Ahumairangi Investment Management’s Quest Diagnostics DGX Stock Holding History

Te Ahumairangi Investment Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.92M Sell
30,222
-4,314
-12% -$838K 0.99% 34
2025
Q4 		$5.99M Sell
34,536
-3,922
-10% -$714K 1.07% 27
2025
Q3 		$7.33M Sell
38,458
-1,540
-4% -$273K 1.25% 22
2025
Q2 		$7.18M Buy
39,998
+944
+2% +$164K 1.29% 22
2025
Q1 		$6.61M Sell
39,054
-4,140
-10% -$680K 1.4% 19
2024
Q4 		$6.52M Sell
43,194
-6,810
-14% -$1.06M 1.36% 20
2024
Q3 		$7.72M Buy
50,004
+1,520
+3% +$227K 1.37% 20
2024
Q2 		$6.64M Sell
48,484
-8,640
-15% -$1.18M 1.28% 26
2024
Q1 		$7.6M Buy
57,124
+8,100
+17% +$1.05M 1.32% 26
2023
Q4 		$6.76M Sell
49,024
-17,260
-26% -$2.27M 1.28% 28
2023
Q3 		$8.08M Sell
66,284
-145
-0.2% -$19.3K 1.31% 25
2023
Q2 		$9.34M Buy
66,429
+5,310
+9% +$732K 1.27% 25
2023
Q1 		$8.65M Sell
61,119
-695
-1% -$99.4K 1.24% 24
2022
Q4 		$9.67M Sell
61,814
-12,435
-17% -$1.79M 1.51% 20
2022
Q3 		$9.11M Sell
74,249
-1,405
-2% -$185K 1.55% 20
2022
Q2 		$10.1M Sell
75,654
-1,955
-3% -$266K 1.52% 20
2022
Q1 		$10.6M Sell
77,609
-847
-1% -$118K 1.44% 21
2021
Q4 		$13.6M Sell
78,456
-5,400
-6% -$822K 1.75% 13
2021
Q3 		$12.2M Sell
83,856
-10,902
-12% -$1.6M 1.68% 14
2021
Q2 		$12.5M Buy
94,758
+2,600
+3% +$340K 1.63% 14
2021
Q1 		$11.8M Buy
92,158
+18,500
+25% +$2.28M 1.52% 17
2020
Q4 		$8.78M Buy
73,658
+12,800
+21% +$1.56M 1.22% 28
2020
Q3 		$6.97M Buy
+60,858
New +$7.19M 1.19% 26

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Te Ahumairangi Investment Management's DGX Position: Q1 2026 in Review

Te Ahumairangi Investment Management reduced its Quest Diagnostics (DGX) stake by 12% in Q1 2026, selling an estimated $838K and leaving 30,222 shares worth $5.92M. The position accounts for 0.99% of the portfolio, ranked #34.

Te Ahumairangi Investment Management first reported a position in DGX in Q3 2020 and has held it in 23 quarters since. The position peaked at $13.6M in Q4 2021. 1,066 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Te Ahumairangi Investment Management held 30,222 shares of Quest Diagnostics worth $5.92M as of Q1 2026.
  • Te Ahumairangi Investment Management sold 4,314 Quest Diagnostics shares in Q1 2026, an estimated $838K.
  • Quest Diagnostics made up 0.99% of Te Ahumairangi Investment Management's portfolio in Q1 2026, its #34 holding.
  • Te Ahumairangi Investment Management first reported a position in Quest Diagnostics in Q3 2020 and has held it in 23 quarters since.
  • Te Ahumairangi Investment Management's Quest Diagnostics position peaked at $13.6M in Q4 2021.
  • 1,066 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Te Ahumairangi Investment Management's 13F filing for Q1 2026, filed 15 May 2026.